Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer

被引:71
作者
Zhou, Liangfu [1 ]
Zhao, Bin [1 ]
Zhang, Lixiu [1 ]
Wang, Shenghang [1 ]
Dong, Dandan [1 ]
Lv, Huanhuan [1 ,2 ,3 ]
Shang, Peng [2 ,3 ]
机构
[1] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China
[2] Northwestern Polytech Univ, Res & Dev Inst Shenzhen, Shenzhen 518057, Peoples R China
[3] Northwestern Polytech Univ, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China
基金
中国国家自然科学基金;
关键词
iron metabolism; cancer; iron chelators; targeted therapy; redox homeostasis; HEPATOCELLULAR-CARCINOMA CELLS; TRANSCRIPTION FACTOR NRF2; TRANSFERRIN RECEPTOR 2; HUMAN BREAST-CANCER; H-FERRITIN; IN-VIVO; REGULATORY PROTEIN-1; ANTITUMOR-ACTIVITY; PROSTATE-CANCER; TUMOR-GROWTH;
D O I
10.3390/ijms19051545
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is an essential element for the growth and proliferation of cells. Cellular iron uptake, storage, utilization and export are tightly regulated to maintain iron homeostasis. However, cellular iron metabolism pathways are disturbed in most cancer cells. To maintain rapid growth and proliferation, cancer cells acquire large amounts of iron by altering expression of iron metabolism- related proteins. In this paper, normal cellular iron metabolism and the alterations of iron metabolic pathways in cancer cells were summarized. Therapeutic strategies based on targeting the altered iron metabolism were also discussed and disrupting redox homeostasis by intracellular high levels of iron provides new insight for cancer therapy. Altered iron metabolism constitutes a promising therapeutic target for cancer therapy.
引用
收藏
页数:21
相关论文
共 190 条
  • [1] Transferrin receptor 1
    Aisen, P
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) : 2137 - 2143
  • [2] The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis
    Alkhateeb, Ahmed A.
    Connor, James R.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 245 - 254
  • [3] Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells
    Andolfo, Immacolata
    De Falco, Luigia
    Asci, Roberta
    Russo, Roberta
    Colucci, Simona
    Gorrese, Marisa
    Zollo, Massimo
    Iolascon, Achille
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1244 - 1252
  • [4] Medical progress: Disorders of iron metabolism
    Andrews, NC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) : 1986 - 1995
  • [5] Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
    Arosio, Paolo
    Levi, Sonia
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2010, 1800 (08): : 783 - 792
  • [6] Distinct Mechanisms of Ferritin Delivery to Lysosomes in Iron-Depleted and Iron-Replete Cells
    Asano, Takeshi
    Komatsu, Masaaki
    Yamaguchi-Iwai, Yuko
    Ishikawa, Fuyuki
    Mizushima, Noboru
    Iwai, Kazuhiro
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (10) : 2040 - 2052
  • [7] miR-20a regulates expression of the iron exporter ferroportin in lung cancer
    Babu, Kamesh R.
    Muckenthaler, Martina U.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (03): : 347 - 359
  • [8] Ascorbate metabolism and its regulation in animals
    Banhegyi, G
    Braun, L
    Csala, M
    Puskas, F
    Mandl, J
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (05) : 793 - 803
  • [9] Iron addiction: a novel therapeutic target in ovarian cancer
    Basuli, D.
    Tesfay, L.
    Deng, Z.
    Paul, B.
    Yamamoto, Y.
    Ning, G.
    Xian, W.
    McKeon, F.
    Lynch, M.
    Crum, C. P.
    Hegde, P.
    Brewer, M.
    Wang, X.
    Miller, L. D.
    Dyment, N.
    Torti, F. M.
    Torti, S. V.
    [J]. ONCOGENE, 2017, 36 (29) : 4089 - 4099
  • [10] BECTON DL, 1988, CANCER RES, V48, P7189